Prolacta Bioscience makes human milk-based fortifiers and nutrition products for infants.
Founded in 1999 and based in City of Industry, US, Prolacta Bioscience develops human milk-based fortifiers and nutritional products for neonatal intensive care units. Its products are intended to support growth and feeding in preterm and critically ill infants. The company sells to hospitals and healthcare facilities. Its latest reported round was USD 35.00 mn in venture debt on December 6, 2016, led by Essex Woodlands and including Aisling Capital and Health Evolution Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in